Phase I experience with emetine hydrochloride (NSC 33669) as an antitumor agent

Frank Panettiere, Charles A. Coltman

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I experience with emetine hydrochloride (NSC 33669) as an antitumor agent'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science